InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Mack Roszell III, 董事. Director active across 1 company, notably Sanara MedTech Inc.. Aggregated, 5 filings have been logged. Activity tracked since 9 February 2022. The latest transaction was disclosed on 22 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Mack Roszell III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
3,433 股0Common StockSEC:0001641172-25-012542:0
3,604 股0Common StockSEC:0001493152-24-023961:0
2,802 股0Common StockSEC:0001493152-23-020181:0
4,570 股0Common StockSEC:0001493152-22-018959:0
2,125 股0Common StockSEC:0001493152-22-004094:0
5 条申报中的 5 条
About Mack Roszell III
Mack Roszell III is Administrateur at Sanara MedTech Inc. (XNAS). The file shows 5 filings in total, and the sampled filings cover the period from 2022-02-11 to 2025-05-27, with a modal transaction nature listed as Attribution. The aggregated buy and sell amounts across the sampled filings are EUR 0 and EUR 0.
